- Lobbying
- Lobbying by Metabiota
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Laura Bozell | LA House Mem Offce (McCrery),Prof Staff Ways&MeansCmte(Camp) LA House Member Office (McCrery), Prof Staff Ways & Means Cmte (Camp) |
Mark Murray | Prof Staff House Cmte Office |
Mark Mioduski | Prof Staff;House Approps Cmte (Obey) Prof Staff; House Approps Cmte (Obey) |
James Richards | COS House Member Office (Pearce); Director IGA USDA Appropriations Associate House Mem Office (Skeen & Bonilla) COS House Member Office (Pearce); Director IGA USDA; Appropriations Associate House Member Office (Skeen & Bonilla) |
Erik Fatemi | Prof Staff Senate Approps Cmte |
Todd Webster | Communications Senate Member Office (Murray, Daschle), Chief of Staff Senate Member Office (Coons) |
Michael Smith | n/a |
John Leggieri | n/a |
Joseph Bischoff PhD | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q2 Report
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Registration
Issue(s) they said they’d lobby about: Public health, public health funding, global health.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate